Dongsung Pharm (002210) - Total Liabilities

Latest as of June 2025: ₩107.40 Billion KRW ≈ $72.78 Million USD

Based on the latest financial reports, Dongsung Pharm (002210) has total liabilities worth ₩107.40 Billion KRW (≈ $72.78 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Dongsung Pharm - Total Liabilities Trend (2008–2024)

This chart illustrates how Dongsung Pharm's total liabilities have evolved over time, based on quarterly financial data. See Dongsung Pharm current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Dongsung Pharm Competitors by Total Liabilities

The table below lists competitors of Dongsung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Priceworth International Bhd KLSE:7123	Malaysia	RM149.37 Million
BIORETEC OY F:0TN	Germany	€1.92 Million
Marvel Gold Ltd AU:MVL	Australia	AU$598.75K
Western Mines Group Ltd AU:WMG	Australia	AU$251.75K
Arcure SA PA:ALCUR	France	€10.76 Million
HM Inwest S.A. WAR:HMI	Poland	zł157.19 Million
Kiang Huat Sea Gull Trading Frozen Food Public Company Limited BK:CHOTI	Thailand	฿1.71 Billion
Saray Matbaacilik Kagitcilik Kirtasiyecilik Ticaret ve Sanayi AS IS:SAMAT	Turkey	TL155.52 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Dongsung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Dongsung Pharm.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.73	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dongsung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dongsung Pharm (2008–2024)

The table below shows the annual total liabilities of Dongsung Pharm from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩96.73 Billion ≈ $65.56 Million	+28.69%
2023-12-31	₩75.17 Billion ≈ $50.94 Million	+15.84%
2022-12-31	₩64.89 Billion ≈ $43.98 Million	+11.61%
2021-12-31	₩58.14 Billion ≈ $39.40 Million	-17.84%
2020-12-31	₩70.77 Billion ≈ $47.96 Million	+14.83%
2019-12-31	₩61.63 Billion ≈ $41.77 Million	-25.49%
2018-12-31	₩82.71 Billion ≈ $56.05 Million	+38.05%
2017-12-31	₩59.91 Billion ≈ $40.60 Million	-14.12%
2016-12-31	₩69.77 Billion ≈ $47.28 Million	+8.37%
2011-12-31	₩64.38 Billion ≈ $43.63 Million	-6.30%
2010-12-31	₩68.71 Billion ≈ $46.56 Million	+14.63%
2009-12-31	₩59.94 Billion ≈ $40.62 Million	+5.62%
2008-12-31	₩56.75 Billion ≈ $38.46 Million	--

About Dongsung Pharm

KO:002210 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$16.09 Million

₩23.75 Billion KRW

Market Cap Rank

#25804 Global

#1883 in Korea

Share Price

₩973.00

Change (1 day)

+0.00%

52-Week Range

₩973.00 - ₩973.00

All Time High

₩45800.00